<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate the rheumatic complications in patients with myelodysplastic and <z:mpath ids='MPATH_512'>myeloproliferative diseases</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A retrospective chart review of patients with a <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">rheumatic disease</z:e> and either a myelodysplastic or <z:hpo ids='HP_0005547'>myeloproliferative disorder</z:hpo> diagnosed on bone marrow examination </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Nine patients were identified, 5 with myelodysplastic and 4 with <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0162323" disease_type="Disease or Syndrome" abbrv="">Polyarthritis</z:e> was the most common rheumatic presentation, occurring in 6 patients with a positive rheumatoid factor in 4 </plain></SENT>
<SENT sid="4" pm="."><plain>Necrotizing <z:hpo ids='HP_0002633'>vasculitis</z:hpo> complicated the course in 3 patients </plain></SENT>
<SENT sid="5" pm="."><plain>Autoantibodies and <z:hpo ids='HP_0010702'>hypergammaglobulinemia</z:hpo> were present in the majority of patients </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: There is an association between <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> caused by proliferation of bone marrow derived pluripotent stem cells and rheumatic disorders </plain></SENT>
</text></document>